By Elliot Weld (March 2, 2023, 4:46 PM EST) — Eli Lilly & Co. has pushed back on rival Teva Pharmaceuticals’ request to triple a $176.5 million migraine drug patent infringement verdict, saying Teva’s motion resorted to “vitriol” by misconstruing the record and presenting facts selectively….